Brief Type: Advocacy Letter

Public Comment on December 4-5, 2025 ACIP Meeting

December 1, 2025

This comment on Docket No. CDC-2025-0783 focuses on ACIP’s December agenda—specifically the Hepatitis B birth-dose discussions, possible changes to the childhood and adolescent schedule, and the implications for VFC coverage. It also addresses the committee’s recent restructuring and reduced transparency in Work Group processes, and the downstream effects on vaccine access, HIV and viral hepatitis prevention, immunocompromised populations, and the health of older adults.

Read More

Public Comment on September 18-19, 2025 ACIP Meeting

September 15, 2025

On behalf of HealthHIV and the National Coalition for LGBTQ Health, this comment on Docket No. CDC-2025-0454 addresses ACIP membership changes, agenda items on COVID-19, Hepatitis B, MMRV, RSV, and Vaccines for Children, and the implications for vaccine access, HIV, viral hepatitis, immune deficiency care, and older adult health.

Read More

On the House’s Proposed FY 2026 Spending Bill

September 2, 2025

House Republicans’ FY26 budget bill would eliminate all federal HIV prevention funding, cut the Ryan White Program by 20% ($525M), collapse STI and viral hepatitis funding into block grants, and dismantle decades of bipartisan progress in HIV care, prevention, and public health.

Read More

Personal Responsibility and Work Opportunity Reconciliation Act of 1996 Proposed Changes Comments

August 14, 2025

Comments on proposed changes to the Personal Responsibility and Work Opportunity Reconciliation Act of 1996.

Read More

Medicare Drug Price Negotiation Program Draft Guidance Comments

Comments regarding Medicare Drug Price Negotiation Program draft guidance.

Read More

Medicare Cost Smoothing Fact Sheet

A fact sheet regarding upcoming Medicare Cost Smoothing.

Read More

Medicare Advantage and Prescription Drug Plans Bid Pricing Tool Proposed Changes Comments

Comments on proposed changes to the Medicare Advantage and Prescription Drug Plans Bid Pricing Tool.

Read More

Medicare Part D 2024-2025 Plans OPWH Implications Comments

Comments regarding Medicare Part D 2024-2025 Plans.

Read More

On the Death of Chevron Deference, and the Strange Life of the USPSTF

July 14, 2025

Analysis of the ongoing regulatory and public health effects of the overturning of Chevron Deference and the Braidwood SCOTUS ruling.

Read More

Conditional Coverage: When Paperwork Replaces Policy in Medicaid

July 10, 2025

Comments on projected Medicaid coverage losses under the “One Big Beautiful Bill”

Read More

Medicare Part D/IRA PAWH Implications Comments

July 3, 2025

Comments to the HHS Office of Intergovernmental and External Affairs regarding implementation considerations for Medicare Part D and the Inflation Reduction Act (IRA) for people aging with HIV (PAWH).

Read More

Senate HELP Committee Leadership PBM Reform Comments

Comments to the leadership of the US Senate Health, Education, Labor, and Pensions (HELP) Committee regarding proposed reforms to the Pharmacy Benefit Manager (PBM) system.

Read More